Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

about

Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

Item

http://www.wikidata.org/entity/Q43150240

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

@en

Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

@nl

type

Item

label

Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

@en

Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

@nl

prefLabel

Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

@en

Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

@nl

P1476

Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

@en

P2093

Alana C Cecchi

http://www.w3.org/2001/XMLSchema#string

Amy J Reid

http://www.w3.org/2001/XMLSchema#string

Dianna M Milewicz

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis

Heritable collagen disorders: the paradigm of the Ehlers-Danlos syndrome

Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development

Cutaneous wound healing

Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development.

Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.

Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).

Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial.

The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome.

P304

5-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1161/CIRCGENETICS.114.000507

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24550430

http://www.w3.org/2001/XMLSchema#string

P921

Ehlers-Danlos syndrome

P932

4331049

http://www.w3.org/2001/XMLSchema#string